Greg Crawford, dean of the College of Science at the University of Notre Dame, will be cycling 3,250 miles from Boston to Pebble Beach, Calif., to raise awareness and funds for research to find a cure for Niemann-Pick Type C (NPC) disease. His third cross-country ride will start May 21 (Monday) and conclude June 22 (Friday), in time for the Parseghian Classic, a golf fundraiser at Pebble Beach Resorts.

The “Road to Discovery” bicycle ride demonstrates Notre Dame’s commitment to research to find a cure or treatments for the devastating disease that took the lives of three grandchildren of former Notre Dame head football coach Ara Parseghian. Read More

Harper Cancer Research Institute (HCRI) Research Day on April 23 (Monday) will gather cancer researchers from the University of Notre Dame and Indiana University School of Medicine-South Bend (IUSM-SB) in an afternoon of exchange and discussion. A keynote address by Beatrice Knudsen, M.D., Ph.D., will discuss “Tissue Banking for Genomic Research and Personalized Medicine.”

Knudsen is the medical director for Cedars-Sinai Advanced Biobank, director of translational pathology at Cedars-Sinai Medical Center and a member of the HCRI external advisory committee. Her presentation is free and open to the public. Read More

Researchers from the University of Notre Dame’s Eck Institute for Global Health have developed a “gene chip” to contribute to the identification of malaria drug resistance, an effort that will allow for real-time response in modified treatment strategies for this devastating disease.

The discovery is described in a paper appearing in the latest early online edition of the journal Science. The team of researchers includes Notre Dame’s Michael Ferdig, associate professor of biological sciences; doctoral student Becky Miller; and John Tan, managing director of the Genomics Core Facility, in collaboration with Tim Anderson of Texas Biomedical Research Institute and Francois Nosten, M.D., of the Shoklo Malaria Research Unit in Thailand. Read More